How it works:
Semaglutide works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake. The medication dose may be increased gradually over 12 weeks to 2.4 mg once weekly to reduce gastrointestinal side effects.
Some reported benefits of Semaglutide include:
- Reduced body weight, lipid, blood pressure, inflammatory markers & oxidative stress
- Suppresses Appetite
- Enhances insulin synthesis & secretion
- Promotes satiety (sensations of fullness in the brain)
- And more
Dosing medication is done in phases:
- Phase I (Month 1)- consists of 0.25mg/0.5mg/ml of Semaglutide/Cyanocobalamin given subcutaneously Once every week for 4 weeks.
- Phase II (Month 2)- consists of 0.5mg/0.5mg/ml of Semaglutide/Cyanocobalamin given subcutaneously Once every week for 4
weeks.
- Phase III (Month 3)- consists of 1mg/0.5mg/ml of Semaglutide/Cyanocobalamin given subcutaneously Once every week for 4 weeks.
- Phase IV (Month 4) - consists of 1.7mg/0.5mg/ml of Semaglutide/Cyanocobalamin given subcutaneously Once every week for 4 weeks
- Any continuation past four months must be evaluated by a healthcare provider to ensure safety and efficacy for weight loss management.
Side effects:
Semaglutide: Common side effects may include nausea, vomiting, diarrhea, constipation, stomach pain, headache, tiredness, upset stomach, dizziness, bloating, belching, gas , stomach flu and heartburn. Serious side effects may include pancreatitis, gallstones, low blood sugar (hypoglycemia), kidney problems including kidney failure, chances in vision in peoples with type 2 diabetes, increased resting heart rate, depression or thoughts of suicide.
Cyanocobalamin: Common side effects may include dizziness, headache, feeling tired or weak, feeling nervous and excitable, upset stomach, diarrhea, or signs of a common cold.
PLEASE call your healthcare provider if you experience any serious or unusual side effect or have any questions.
Informed Consent:
By accepting the terms of this informed consent below you are in agreement with enrollment in a medical weight loss program using semaglutide that involves a reduced calorie diet, increased physical activity & nutrition counseling.
Do not use this medication if you or your family have ever had a type of thyroid cancer called Medullary Thyroid Carcinoma(MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEM2).
Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. It is not known if Semaglutide will cause thyroid tumors or MTC in people. In studies with rodents, Semaglutide and medications that work like Semaglutide causes thyroid tumors, including thyroid cancer.
Female patient(s) are also agreeing that they understand the following:
- pregnancy testing prior to initiating treatment
- Immediate discontinuation if they suspect they could be pregnant any time after starting treatment
- the need for contraception for two months after discontinuing semaglutide.
FDA Approved Treatment for Weight Management